drugset / Trial / NCT06272409
Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of DEP114 in the treatment of Moderate to Severe Persistent Allergic Rhinitis in children aged between 6 and 11 years.
Timeline
- Start
- 2025-02-15
- Primary completion
- 2025-03-15
- Completion
- 2027-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DEP114 | Unknown | — | Oral |
| Comparator | Desloratadine | Small molecule | 0.5 mg/ml | Oral |